Growth Metrics

CareDx (CDNA) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to 0.25%.

  • CareDx's EBITDA Margin rose 163100.0% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.66%, marking a year-over-year increase of 698100.0%. This contributed to the annual value of 12.21% for FY2024, which is 847600.0% up from last year.
  • As of Q3 2025, CareDx's EBITDA Margin stood at 0.25%, which was up 163100.0% from 12.83% recorded in Q2 2025.
  • CareDx's EBITDA Margin's 5-year high stood at 97.46% during Q4 2024, with a 5-year trough of 187.03% in Q4 2023.
  • Over the past 5 years, CareDx's median EBITDA Margin value was 19.44% (recorded in 2021), while the average stood at 22.24%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -1638200bps in 2023, then skyrocketed by 2844900bps in 2024.
  • Over the past 5 years, CareDx's EBITDA Margin (Quarter) stood at 19.44% in 2021, then dropped by -19bps to 23.21% in 2022, then plummeted by -706bps to 187.03% in 2023, then surged by 152bps to 97.46% in 2024, then crashed by -100bps to 0.25% in 2025.
  • Its EBITDA Margin stands at 0.25% for Q3 2025, versus 12.83% for Q2 2025 and 15.79% for Q1 2025.